- Home
- NXL vs BOF Comparison
NXL vs BOF Comparison
Compare NXL & BOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXL
- BOF
- Stock Information
- Founded
- NXL 2010
- BOF 2017
- Country
- NXL United States
- BOF United States
- Employees
- NXL N/A
- BOF N/A
- Industry
- NXL Medical Specialities
- BOF Packaged Foods
- Sector
- NXL Health Care
- BOF Consumer Staples
- Exchange
- NXL Nasdaq
- BOF Nasdaq
- Market Cap
- NXL 21.0M
- BOF 21.2M
- IPO Year
- NXL 2022
- BOF 2023
- Fundamental
- Price
- NXL $0.95
- BOF $2.67
- Analyst Decision
- NXL Strong Buy
- BOF
- Analyst Count
- NXL 1
- BOF 0
- Target Price
- NXL $5.00
- BOF N/A
- AVG Volume (30 Days)
- NXL 87.1K
- BOF 87.1K
- Earning Date
- NXL 08-07-2025
- BOF 08-13-2025
- Dividend Yield
- NXL N/A
- BOF N/A
- EPS Growth
- NXL N/A
- BOF N/A
- EPS
- NXL N/A
- BOF N/A
- Revenue
- NXL $131,065.00
- BOF $8,242,843.00
- Revenue This Year
- NXL $79.59
- BOF N/A
- Revenue Next Year
- NXL $334.65
- BOF N/A
- P/E Ratio
- NXL N/A
- BOF N/A
- Revenue Growth
- NXL N/A
- BOF 96.47
- 52 Week Low
- NXL $0.59
- BOF $0.61
- 52 Week High
- NXL $4.49
- BOF $4.11
- Technical
- Relative Strength Index (RSI)
- NXL 30.94
- BOF 61.65
- Support Level
- NXL $0.89
- BOF $2.22
- Resistance Level
- NXL $1.03
- BOF $2.79
- Average True Range (ATR)
- NXL 0.08
- BOF 0.17
- MACD
- NXL -0.00
- BOF 0.06
- Stochastic Oscillator
- NXL 18.75
- BOF 70.45
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
About BOF BranchOut Food Inc.
Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.